Published on Novartis Ireland HCP Portal (https://www.hcp.novartis.ie)

Home > Printer-friendly > COSENTYX® (secukinumab)

Cosentyx (secukinumab) [1]

________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________

Cosentyx (secukinumab) in Rheumatology [2]

Cosentyx is the first and only fully human targeted IL-17A inhibitor that offers fast and lasting relief from the signs and symptoms of PsA* and axSpA†‡

Rate this content: 
Average: 3 (2 votes)
Source URL:https://www.hcp.novartis.ie/medicines/rheumatology/cosentyx

Links
[1] https://www.hcp.novartis.ie/medicines/rheumatology/cosentyx [2] https://www.hcp.novartis.ie/medicines/rheumatology/why-cosentyx